Núria Juanpere

1.0k total citations
40 papers, 669 citations indexed

About

Núria Juanpere is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Núria Juanpere has authored 40 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 15 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in Núria Juanpere's work include Prostate Cancer Treatment and Research (21 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Prostate Cancer Diagnosis and Treatment (10 papers). Núria Juanpere is often cited by papers focused on Prostate Cancer Treatment and Research (21 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Prostate Cancer Diagnosis and Treatment (10 papers). Núria Juanpere collaborates with scholars based in Spain, United States and France. Núria Juanpere's co-authors include Josep Lloreta, Marta Lorenzo, Silvia de Muga, Sérgio Serrano, Sílvia Hernández, José A. Lorente, Laia Agell, Marta Salido, Lluís Fumadó and Joaquim Bellmunt and has published in prestigious journals such as Gut, Scientific Reports and American Journal Of Pathology.

In The Last Decade

Núria Juanpere

37 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Núria Juanpere Spain 15 255 250 205 166 158 40 669
Güneş Güner Türkiye 15 166 0.7× 233 0.9× 351 1.7× 75 0.5× 308 1.9× 39 714
Alexander Sankin United States 15 357 1.4× 441 1.8× 369 1.8× 175 1.1× 265 1.7× 49 925
William Crabtree United States 13 224 0.9× 142 0.6× 373 1.8× 123 0.7× 188 1.2× 29 753
Grace C. Blitzer United States 9 189 0.7× 132 0.5× 135 0.7× 121 0.7× 227 1.4× 26 613
Matthew J. Wasco United States 12 198 0.8× 252 1.0× 301 1.5× 101 0.6× 111 0.7× 19 681
Christine Loo Australia 12 183 0.7× 81 0.3× 120 0.6× 46 0.3× 94 0.6× 36 482
Walter M. Klein United States 9 171 0.7× 74 0.3× 120 0.6× 91 0.5× 325 2.1× 13 568
Horst Schlechte Germany 13 248 1.0× 173 0.7× 158 0.8× 148 0.9× 207 1.3× 30 591
Marie‐Aude Lefrère‐Belda France 10 387 1.5× 126 0.5× 423 2.1× 72 0.4× 139 0.9× 12 817
Zerina Jasarevic Austria 11 74 0.3× 105 0.4× 168 0.8× 221 1.3× 157 1.0× 19 529

Countries citing papers authored by Núria Juanpere

Since Specialization
Citations

This map shows the geographic impact of Núria Juanpere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Núria Juanpere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Núria Juanpere more than expected).

Fields of papers citing papers by Núria Juanpere

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Núria Juanpere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Núria Juanpere. The network helps show where Núria Juanpere may publish in the future.

Co-authorship network of co-authors of Núria Juanpere

This figure shows the co-authorship network connecting the top 25 collaborators of Núria Juanpere. A scholar is included among the top collaborators of Núria Juanpere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Núria Juanpere. Núria Juanpere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellmunt, Joaquim, Júlia Perera‐Bel, Gardenia Vargas‐Parra, et al.. (2025). Prognostic Value of PARP1 and PARP2 Copy Number Alterations in Prostate Cancer. Laboratory Investigation. 105(6). 104171–104171.
3.
Juanpere, Núria, Marta Lorenzo, David López, et al.. (2023). Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(2). 281–290. 2 indexed citations
4.
Everaerts, Wouter, Jochen Walz, J.M. Abascal Junquera, et al.. (2023). A Multicentre Clinical Trial Evaluating a Drop-in Gamma Probe for Minimally Invasive Sentinel Lymph Node Dissection in Prostate Cancer. European Urology Focus. 10(1). 32–40. 2 indexed citations
5.
Jong, Joep J. de, Begoña P. Valderrama, Júlia Perera‐Bel, et al.. (2022). Non-muscle-invasive micropapillary bladder cancer has a distinct lncRNA profile associated with unfavorable prognosis. British Journal of Cancer. 127(2). 313–320. 13 indexed citations
6.
Junquera, J.M. Abascal, et al.. (2021). Concomitant intraductal carcinoma of the prostate and response to hormonal therapy in metastatic prostate carcinoma. Actas Urológicas Españolas (English Edition). 45(6). 455–460. 1 indexed citations
7.
Bowden, Michaela, Rosa Nadal, Chensheng W. Zhou, et al.. (2020). Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer. Scientific Reports. 10(1). 20135–20135. 9 indexed citations
8.
Rodríguez‐Vida, Alejo, Núria Juanpere, Oriol Arpí, et al.. (2019). Novel Oral mTORC1/2 Inhibitor TAK-228 Has Synergistic Antitumor Effects When Combined with Paclitaxel or PI3Kα Inhibitor TAK-117 in Preclinical Bladder Cancer Models. Molecular Cancer Research. 17(9). 1931–1944. 27 indexed citations
9.
Pijuán, Lara, Sergi Mojal, Marta Salido, et al.. (2019). Complementary value of electron microscopy and immunohistochemistry in the diagnosis of non-small cell lung cancer: A potential role for electron microscopy in the era of targeted therapy. Ultrastructural Pathology. 43(6). 237–247. 1 indexed citations
10.
Juanpere, Núria, Marta Lorenzo, Lluís Fumadó, et al.. (2019). Strong cytoplasmic ETV1 expression has a negative impact on prostate cancer outcome. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 475(4). 457–466. 5 indexed citations
11.
Martínez‐Bosch, Neus, Alejo Rodríguez‐Vida, Núria Juanpere, et al.. (2019). Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities. Nature Reviews Urology. 16(7). 433–445. 26 indexed citations
12.
Lloreta, Josep, Alba Font‐Tello, Núria Juanpere, et al.. (2017). FOXO1 down-regulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression. Human Pathology. 62. 222–231. 17 indexed citations
13.
Hernández, Sílvia, Alba Font‐Tello, Núria Juanpere, et al.. (2016). ConcurrentTMPRSS2-ERGandSLC45A3-ERGrearrangements plusPTENloss are not found in low grade prostate cancer and define an aggressive tumor subset. The Prostate. 76(9). 854–865. 16 indexed citations
14.
Agell, Laia, Sílvia Hernández, Lara Nonell, et al.. (2012). A 12-Gene Expression Signature Is Associated with Aggressive Histological in Prostate Cancer. American Journal Of Pathology. 181(5). 1585–1594. 40 indexed citations
15.
Lloreta, Josep, Núria Juanpere, Lara Pijuán, et al.. (2011). Cardiac Myxoma with Glandular Differentiation: An Immunohistochemical and Ultrastructural Study. Ultrastructural Pathology. 37(1). 77–82. 5 indexed citations
16.
Galván, Ana B., Marta Salido, Blanca Espinet, et al.. (2011). A multicolor fluorescence in situ hybridization assay: A monitoring tool in the surveillance of patients with a history of non–muscle‐invasive urothelial cell carcinoma. Cancer Cytopathology. 119(6). 395–403. 20 indexed citations
17.
Molero, Xavier, Eva C. Vaquero, Marta Flández, et al.. (2011). Gene expression dynamics after murine pancreatitis unveils novel roles for Hnf1α in acinar cell homeostasis. Gut. 61(8). 1187–1196. 32 indexed citations
18.
Muga, Silvia de, Sílvia Hernández, Laia Agell, et al.. (2010). Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas. Modern Pathology. 23(5). 703–712. 54 indexed citations
19.
Agell, Laia, Sílvia Hernández, Marta Salido, et al.. (2010). PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events. Modern Pathology. 24(3). 443–452. 41 indexed citations
20.
Martín‐Ezquerra, Gemma, Anna Jucglá, Núria Juanpere, et al.. (2009). Treponema pallidum distribution patterns in mucocutaneous lesions of primary and secondary syphilis: an immunohistochemical and ultrastructural study. Human Pathology. 40(5). 624–630. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026